Naturhouse Health Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Naturhouse Health heeft een totaal eigen vermogen van €27.6M en een totale schuld van €1.3M, wat de schuld-eigenvermogensverhouding op 4.6% brengt. De totale activa en totale passiva bedragen respectievelijk €49.0M en €21.4M. De EBIT Naturhouse Health is €14.2M waardoor de rentedekking 36.4 is. Het heeft contanten en kortetermijnbeleggingen van €27.7M.

Belangrijke informatie

4.6%

Verhouding schuld/eigen vermogen

€1.26m

Schuld

Rente dekkingsratio	36.4x
Contant	€27.74m
Aandelen	€27.60m
Totaal verplichtingen	€21.40m
Totaal activa	€49.00m

Recente financiële gezondheidsupdates

Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet

Oct 05

Is Naturhouse Health (BME:NTH) A Risky Investment?

Mar 24

Recent updates

Can Mixed Fundamentals Have A Negative Impact on Naturhouse Health, S.A. (BME:NTH) Current Share Price Momentum?

Mar 06

A Look At The Intrinsic Value Of Naturhouse Health, S.A. (BME:NTH)

Jan 14

Would Shareholders Who Purchased Naturhouse Health's (BME:NTH) Stock Five Years Be Happy With The Share price Today?

Dec 01

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €34.5M ) NTH } overtreffen de korte termijn passiva ( €16.5M ).

Langlopende schulden: De kortetermijnactiva NTH ( €34.5M ) overtreffen de langetermijnschulden ( €4.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: NTH heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van NTH is de afgelopen 5 jaar gedaald van 14.1% naar 4.6%.

Schuldendekking: De schuld van NTH wordt goed gedekt door de operationele kasstroom ( 1218.2% ).

Rentedekking: De rentebetalingen op de schuld van NTH worden goed gedekt door EBIT ( 36.4 x dekking).

Naturhouse Health Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet

Is Naturhouse Health (BME:NTH) A Risky Investment?

Recent updates

Some May Be Optimistic About Naturhouse Health's (BME:NTH) Earnings

First half 2024 earnings released: EPS: €0.097 (vs €0.12 in 1H 2023)

New minor risk - Financial data availability

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of €0.081 per share

Now 20% overvalued after recent price rise

Now 21% overvalued after recent price rise

Now 20% overvalued after recent price rise

Upcoming dividend of €0.041 per share

Now 20% overvalued

We Think Naturhouse Health's (BME:NTH) Solid Earnings Are Understated

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Now 20% undervalued

New minor risk - Financial data availability

Upcoming dividend of €0.041 per share at 5.7% yield

New minor risk - Financial data availability

Now 20% undervalued after recent price drop

Upcoming dividend of €0.041 per share at 5.7% yield

Now 21% undervalued

Full year 2022 earnings released: EPS: €0.16 (vs €0.22 in FY 2021)

Now 20% undervalued

Calculating The Fair Value Of Naturhouse Health, S.A. (BME:NTH)

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet

First half 2022 earnings released: EPS: €0.11 (vs €0.081 in 1H 2021)

Less than half of directors are independent

Upcoming dividend of €0.16 per share

Full year 2021 earnings: EPS and revenues miss analyst expectations

Naturhouse Health, S.A. (BME:NTH) acquired 24.8% stake in ICHEM Sp. z o.o. from Zamodiet Sa for €3.2 million.

What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

Second quarter 2021 earnings released: EPS €0.081 (vs €0.02 in 2Q 2020)

Upcoming dividend of €0.049 per share

What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

Is Naturhouse Health (BME:NTH) A Risky Investment?

Can Mixed Fundamentals Have A Negative Impact on Naturhouse Health, S.A. (BME:NTH) Current Share Price Momentum?

Full year 2020 earnings released: EPS €0.16 (vs €0.22 in FY 2019)

Revenue misses expectations

A Look At The Intrinsic Value Of Naturhouse Health, S.A. (BME:NTH)

Investor sentiment improved over the past week

New 90-day high: €1.69

Third quarter 2020 earnings released: EPS €0.064

Would Shareholders Who Purchased Naturhouse Health's (BME:NTH) Stock Five Years Be Happy With The Share price Today?

Market bids up stock over the past week

New 90-day high: €1.47

Market bids up stock over the past week

New 90-day low: €1.17

First half earnings released

New 90-day low - €1.32

New 90-day low - €1.41

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven